Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers. [electronic resource]
Producer: 20160407Description: 4127-35 p. digitalISSN:- 1177-8881
- Administration, Oral
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Area Under Curve
- Chemistry, Pharmaceutical
- Cross-Over Studies
- Drug Combinations
- Esomeprazole -- administration & dosage
- Half-Life
- Healthy Volunteers
- Humans
- Male
- Metabolic Clearance Rate
- Middle Aged
- Models, Biological
- Naproxen -- administration & dosage
- Proton Pump Inhibitors -- administration & dosage
- Republic of Korea
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.